These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

609 related articles for article (PubMed ID: 30094722)

  • 1. Lacidipine Amorphous Solid Dispersion Based on Hot Melt Extrusion: Good Miscibility, Enhanced Dissolution, and Favorable Stability.
    Xi L; Song H; Wang Y; Gao H; Fu Q
    AAPS PharmSciTech; 2018 Oct; 19(7):3076-3084. PubMed ID: 30094722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactive Melt Extrusion To Improve the Dissolution Performance and Physical Stability of Naproxen Amorphous Solid Dispersions.
    Liu X; Zhou L; Zhang F
    Mol Pharm; 2017 Mar; 14(3):658-673. PubMed ID: 28135108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation performance and processability window for manufacturing a dual-polymer amorphous solid dispersion via hot-melt extrusion and strand pelletization.
    Hörmann TR; Jäger N; Funke A; Mürb RK; Khinast JG; Paudel A
    Int J Pharm; 2018 Dec; 553(1-2):408-421. PubMed ID: 30326284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The utilization of drug-polymer interactions for improving the chemical stability of hot-melt extruded solid dispersions.
    Guo Z; Lu M; Li Y; Pang H; Lin L; Liu X; Wu C
    J Pharm Pharmacol; 2014 Feb; 66(2):285-96. PubMed ID: 24433427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five-Stage Approach for a Systematic Screening and Development of Etravirine Amorphous Solid Dispersions by Hot-Melt Extrusion.
    Simões MF; Pereira A; Cardoso S; Cadonau S; Werner K; Pinto RMA; Simões S
    Mol Pharm; 2020 Feb; 17(2):554-568. PubMed ID: 31774685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using Flory-Huggins phase diagrams as a pre-formulation tool for the production of amorphous solid dispersions: a comparison between hot-melt extrusion and spray drying.
    Tian Y; Caron V; Jones DS; Healy AM; Andrews GP
    J Pharm Pharmacol; 2014 Feb; 66(2):256-74. PubMed ID: 24192445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hot Melt Extrusion: Development of an Amorphous Solid Dispersion for an Insoluble Drug from Mini-scale to Clinical Scale.
    Agrawal AM; Dudhedia MS; Zimny E
    AAPS PharmSciTech; 2016 Feb; 17(1):133-47. PubMed ID: 26729533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of film-casting technique to investigate drug-polymer miscibility in solid dispersion and hot-melt extrudate.
    Parikh T; Gupta SS; Meena AK; Vitez I; Mahajan N; Serajuddin AT
    J Pharm Sci; 2015 Jul; 104(7):2142-52. PubMed ID: 25917333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selection of the suitable polymer for supercritical fluid assisted preparation of carvedilol solid dispersions.
    Djuris J; Milovanovic S; Medarevic D; Dobricic V; Dapčević A; Ibric S
    Int J Pharm; 2019 Jan; 554():190-200. PubMed ID: 30414899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A New Extrudable Form of Hypromellose: AFFINISOL™ HPMC HME.
    Huang S; O'Donnell KP; Keen JM; Rickard MA; McGinity JW; Williams RO
    AAPS PharmSciTech; 2016 Feb; 17(1):106-19. PubMed ID: 26335416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physicochemical characterization of hot melt extruded bicalutamide-polyvinylpyrrolidone solid dispersions.
    Andrews GP; AbuDiak OA; Jones DS
    J Pharm Sci; 2010 Mar; 99(3):1322-35. PubMed ID: 19798757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel supercritical carbon dioxide impregnation technique for the production of amorphous solid drug dispersions: a comparison to hot melt extrusion.
    Potter C; Tian Y; Walker G; McCoy C; Hornsby P; Donnelly C; Jones DS; Andrews GP
    Mol Pharm; 2015 May; 12(5):1377-90. PubMed ID: 25730138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous production of itraconazole-based solid dispersions by hot melt extrusion: Preformulation, optimization and design space determination.
    Thiry J; Lebrun P; Vinassa C; Adam M; Netchacovitch L; Ziemons E; Hubert P; Krier F; Evrard B
    Int J Pharm; 2016 Dec; 515(1-2):114-124. PubMed ID: 27720874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Controlled Release Polymer-Lipid Formulations Processed by Hot Melt Extrusion.
    Maniruzzaman M; Islam MT; Halsey S; Amin D; Douroumis D
    AAPS PharmSciTech; 2016 Feb; 17(1):191-9. PubMed ID: 26689407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the third component on the aging and crystallization of cinnarizine-soluplus® binary solid dispersion.
    Tian B; Ju X; Yang D; Kong Y; Tang X
    Int J Pharm; 2020 Apr; 580():119240. PubMed ID: 32197983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Situ Salt Formation during Melt Extrusion for Improved Chemical Stability and Dissolution Performance of a Meloxicam-Copovidone Amorphous Solid Dispersion.
    Haser A; Cao T; Lubach JW; Zhang F
    Mol Pharm; 2018 Mar; 15(3):1226-1237. PubMed ID: 29412681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of the effect of spray drying and hot-melt extrusion on the properties of amorphous solid dispersions containing felodipine.
    Mahmah O; Tabbakh R; Kelly A; Paradkar A
    J Pharm Pharmacol; 2014 Feb; 66(2):275-84. PubMed ID: 24433426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hot-melt extrusion process impact on polymer choice of glyburide solid dispersions: The effect of wettability and dissolution.
    Alshafiee M; Aljammal MK; Markl D; Ward A; Walton K; Blunt L; Korde S; Pagire SK; Kelly AL; Paradkar A; Conway BR; Asare-Addo K
    Int J Pharm; 2019 Mar; 559():245-254. PubMed ID: 30699365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study the influence of formulation process parameters on solubility and dissolution enhancement of efavirenz solid solutions prepared by hot-melt extrusion: a QbD methodology.
    Pawar J; Suryawanshi D; Moravkar K; Aware R; Shetty V; Maniruzzaman M; Amin P
    Drug Deliv Transl Res; 2018 Dec; 8(6):1644-1657. PubMed ID: 29426975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solvent-shift strategy to identify suitable polymers to inhibit humidity-induced solid-state crystallization of lacidipine amorphous solid dispersions.
    Sun M; Wu C; Fu Q; Di D; Kuang X; Wang C; He Z; Wang J; Sun J
    Int J Pharm; 2016 Apr; 503(1-2):238-46. PubMed ID: 26869398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.